Immunoglobulins, normal human, for intravascular [Power / Sample Size]

posted by Dr_Dan  – Germany, 2016-01-14 14:37 (3819 d 05:04 ago) – Posting: # 15827
Views: 6,436

Dear Yura
In a non-controlled (non-comparative) study no control/comparative group (in which subjects are given comparator drug) is used. Is it this what you mean? Pilot study for Proof-of-Concept to evaluate if some Parameters change?
This would be an exploratory study and no formal sample size calculation would be needed. If you want to assess treatment efficacy you need to compare to something (placebo, comparator drug or no treatment at all) and for such a (confirmatory) study you can make a sample size calculation based on the desired outcome (non-inferiority, equivalence or superiority). Please advise.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
270 visitors (0 registered, 270 guests [including 20 identified bots]).
Forum time: 20:42 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5